Kimberly Perez
Co-Director, Clinical Research, Division of Gastrointestinal Oncology · Mass General Brigham
Credentials: · · · ·
History
- Present
Clinical Research · Mass General Brigham
- Present
- 2007–2010
Rhode Island Hospital in
1996–2000
Research
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Cell · 2021 · 479 citations
Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Cancer Discovery · 2018 · 298 citations
Genetics in Medicine · 2019 · 188 citations
30 papers
24 papers
22 papers
21 papers
- HS
19 papers
18 papers
16 papers
13 papers
Clinical trials
- 2023
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Principal investigator · Terminated · Phase 2
Kimberly Perez, MD
- 2020–2024
LY3214996 +/- HCQ in Pancreatic Cancer
Principal investigator · Completed · Phase 2
Kimberly Perez, MD
- 2019–2024
Cabozantinib and Nivolumab for Carcinoid Tumors
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
- 2018–2024
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
Principal investigator · Terminated · Phase 1
Dana-Farber Cancer Institute